Twenty-four Year Single-Center Experience of Hepatitis B Virus Infection in Heart Transplantation
Transplantation Proceedings, 05/11/2012Chen YC et al.
Hepatitis B virus (HBV) reactivation after the heart transplantation was common but usually well controlled with lamivudine treatment. Although posttransplantation liver function deteriorated for a period, there was no HBV infection–related morbidity or mortality. Perioperative hepatitis B immunoglobulin prophylaxis can successfully prevent HBV naïve recipients from infection in some cases, but hepatitis B surface antigen–positive donors should only be considered in high risk situations.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.